SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biogen
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1686 75 0 BIIB
Emcee:  Harold Engstrom Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1561gs: BIIB (OP/N): Expect volatility with FDA decision on Antegren around 11/25 5mopgcw-10/28/2004
1560GS: BIIB (OP/N): No change in view on Antegren 52-Week Range US$64-32 YTD Pricemopgcw-10/28/2004
1559>>SOUTH SAN FRANCISCO, Calif., Oct. 4 /PRNewswire-FirstCall/ -- Genentech,tuck-10/5/2004
1558GS: Biogen Idec, Inc. EPS (FY Dec) 2004E $1.41, 2005E $1.70 Outperform/Neutral (mopgcw-9/29/2004
1557GS: Biogen Idec, Inc. EPS (FY Dec) 2004E $1.41, 2005E $1.70 Outperform/Neutral (mopgcw-9/16/2004
1556Biogen Idec and Sunesis Form Collaboration to Discover and Develop Multiple Smalnigel bates-9/7/2004
1555GS: Biogen Idec, Inc. EPS (FY Dec) 2004E $1.41, 2005E $1.70 Outperform/Neutral (mopgcw-8/5/2004
1554WRH: DOWNGRADING TO HOLD; VALUATION, HIGH EXPECTATIONS, AND LOW PROBABILITY OF Smopgcw-7/15/2004
1553busy yesterday, sharing good stuff as usual? thanks, I'm certain from everyscaram(o)uche-7/10/2004
1552ssb: Biogen Idec (BIIB, Hold, High risk) Reporting date: Wednesday, July 28th,mopgcw-7/9/2004
1551BIIB (OP/N): GS Conference Update: Upbeat presentations 52-Week Range US$64-32 mopgcw-6/14/2004
1550ssb: Digestive Disease Week (DDW) -- May 15-20 Biogen Idec (BIIB): We expect amopgcw-5/17/2004
1549GS: Biogen Idec, Inc. EPS (FY Dec) 2004E $1.34, 2005E $1.70 Outperform/Neutral (mopgcw-5/16/2004
1548Biogen Idec, Inc. EPS (FY Dec) 2004E $1.34, 2005E $1.70 Outperform/Neutral (BIIBmopgcw-5/5/2004
1547GS: Biogen Idec, Inc. EPS (FY Dec) 2004E $1.34, 2005E $1.70 Outperform/Neutral (mopgcw-3/16/2004
1546WACHOVIA SECURITIES BIIB: Q4 2003 Pro Forma Results Earnings Reported Biogen Imopgcw-3/2/2004
1545SSB: BIIB: Plans to File Antegren for MS; Raising Target Price HOLD (2) Himopgcw-2/24/2004
1544GS: Biogen Idec, Inc. EPS (FY Dec) 2003E $1.00, 2004E $1.49 Outperform/Neutral mopgcw-2/23/2004
1543GS: Biogen Idec, Inc. EPS (FY Dec) 2003E $1.00, 2004E $1.49 Outperform/Neutral (mopgcw-2/17/2004
1542from GS: Amgen Inc. EPS (FY Dec) 2004E $2.39, 2005E $2.84 Outperform/Neutral (AMmopgcw-2/9/2004
1541From GS: Biogen Idec, Inc. EPS (FY Dec) 2003E $1.00, 2004E $1.49 Outperform/Neutmopgcw-2/1/2004
1540Amgen Inc. EPS (FY Dec) 2003E $1.90, 2004E $2.39 Outperform/Neutral (AMGN) $62.5mopgcw-1/7/2004
1539GS upgrades: Biotech: Neutral 2004 view w/ tough comparisons. Up BIIB to OP &mopgcw-1/6/2004
1538GS Report 12/8: DNA(OP/N)/BIIB(IL/N): Limited EPS impact from mixed Rituxan datamopgcw-12/14/2003
1537Biogen closed up 7.36% for the week ending 10-31-03 beating the performance of tblackmerlin-11/1/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News